Alx Oncology Holdings (ALXO) Amortizatization of Intangibles (2022 - 2026)

Alx Oncology Holdings' (ALXO) quarterly Amortizatization of Intangibles came in at $199000.0 in Q1 2026, down 62.17% year-on-year from $526000.0 in Q1 2025, and up 6.99% quarter-over-quarter from $186000.0 in Q4 2025.

Alx Oncology Holdings (ALXO) Amortizatization of Intangibles (2022 - 2026) Analysis & Trends

Alx Oncology Holdings has disclosed Amortizatization of Intangibles across 5 years of filings, most recently posting $199000.0 for Q1 2026.

  • Amortizatization of Intangibles for Q1 2026 came in at $199000.0, down 62.17% year-over-year; the trailing twelve-month figure through Mar 2026 was $915000.0 (down 74.79% YoY), and the FY2025 annual result was $1.2 million, down 73.33% from the prior year.
  • Amortizatization of Intangibles came in at $199000.0 for Q1 2026 at Alx Oncology Holdings, up from $186000.0 in the prior quarter.
  • In the past five years, Amortizatization of Intangibles ranged from a high of $1.9 million in Q4 2023 to a low of -$107000.0 in Q1 2022.
  • The 5-year median for Amortizatization of Intangibles is $684000.0 (2022), against an average of $795588.2.
  • Across the five-year window, Amortizatization of Intangibles jumped 41150.0% in 2023 and plunged 79.14% in 2025, its largest moves.
  • Alx Oncology Holdings' Amortizatization of Intangibles stood at $684000.0 in 2022, then jumped by 175.0% to $1.9 million in 2023, then slumped by 60.82% to $737000.0 in 2024, then tumbled by 74.76% to $186000.0 in 2025, then increased by 6.99% to $199000.0 in 2026.
  • The last three Amortizatization of Intangibles figures came in at $199000.0 (Q1 2026), $186000.0 (Q4 2025), and $219000.0 (Q3 2025), per Business Quant data.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Amortizatization of Intangibles (Qtr)
1 Alterity Therapeutics 814,307.08 Bn 814,307.05 Bn - -
2 Belite Bio 55,320.00 Bn 55,320.00 Bn - -
3 Quantum Biopharma 17,149.72 Bn 17,149.72 Bn - 13,267.00
4 Legend Biotech 3,590.00 Bn 3,589.71 Bn 242.10 Mn -
5 Akari Therapeutics 1,650.72 Bn 1,650.72 Bn - -
6 Evaxion A 1,522.09 Bn 1,522.07 Bn - -
7 Psyence Biomedical 229.39 Bn 229.38 Bn - -
8 Vertex Pharmaceuticals 113.09 Bn 105.85 Bn 2.59 Bn -
9 Abivax 90.15 Bn 90.15 Bn - -
10 Alx Oncology Holdings 166.27 Mn 25.95 Mn - 199,000.00

Historic Data

Download Data
DateValue
Mar 31, 2026 199,000.00
Mar 31, 2026 199,000.00
Dec 31, 2025 186,000.00
Dec 31, 2025 186,000.00
Sep 30, 2025 219,000.00
Sep 30, 2025 219,000.00
Jun 30, 2025 311,000.00
Jun 30, 2025 311,000.00
Mar 31, 2025 526,000.00
Mar 31, 2025 526,000.00
Dec 31, 2024 737,000.00
Dec 31, 2024 737,000.00
Sep 30, 2024 1.05 Mn
Sep 30, 2024 1.05 Mn
Jun 30, 2024 1.32 Mn
Jun 30, 2024 1.32 Mn
Mar 31, 2024 1.55 Mn
Mar 31, 2024 1.55 Mn
Dec 31, 2023 1.88 Mn
Dec 31, 2023 1.88 Mn